Argireline vs Eyeseryl

Head-to-head comparison of Argireline (Acetyl Hexapeptide-3) and Eyeseryl (Acetyl Tetrapeptide-5) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArgirelineEyeseryl
CategorySkin & CosmeticSkin & Cosmetic
Full NameAcetyl Hexapeptide-3Acetyl Tetrapeptide-5
Molecular Weight889.0 Da492.5 Da
Half-LifeN/AN/A
Amino Acids64
Typical Dose0.005-10% in finished cosmetic products0.5-2% in eye-area cosmetic products
RouteTopicalTopical
Purity≥98%≥98%
Studies Count4818
Research StatusClinicalClinical

Argireline Benefits

  • expression-line softening
  • anti-wrinkle support
  • cosmetic skin smoothing
  • topical peptide stacking

Eyeseryl Benefits

  • under-eye puffiness reduction
  • cosmetic firming support
  • appearance of dark circles
  • eye-area smoothing

Argireline Dosing

Topical serum/cream 0.005-10%|Apply 1-2x daily to clean skin|Use consistently for 4-12 weeks

Eyeseryl Dosing

Topical eye cream 0.5-2%|Apply 1-2x daily under eyes|Use gently on intact skin only

Argireline Side Effects

  • mild stinging
  • redness or irritation
  • allergic contact dermatitis

Eyeseryl Side Effects

  • eye-area irritation
  • dryness
  • rare contact allergy

Research Overview

Argireline

Acetyl hexapeptide-3 has both in vitro and small human-cosmetic studies supporting a reduction in wrinkle depth or wrinkle appearance. Its best-supported role is as a topical cosmetic peptide rather than a systemic drug.

Eyeseryl

Acetyl tetrapeptide-5 has topical cosmetic literature and formulation studies focused on edema reduction and eye-contour improvement. It is mainly used for appearance benefits rather than as a systemic therapeutic peptide.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Argireline stacks with:

Hyaluronic AcidNiacinamideCeramides

Eyeseryl stacks with:

CaffeineHyaluronic AcidCeramides
anti-wrinkletopicalcosmetic-peptideexpression-lineseye-careanti-aging